You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

SARS-CoV-2 Test Information
Home / Tests / Healthcare Associated Infections / Xpert vanA/vanB

Xpert® vanA/vanB

Rapid vancomycin-resistant enterococci (VRE) screening for active outbreak prevention and control in less than one hour  

Ordering Info
Xpert<sup>®</sup> <em>vanA/vanB</em>

The Need

Effective prevention of healthcare-associated VRE infections begins with active surveillance programs that facilitate timely interventions to decrease the spread of VRE. Cepheid's Xpert® vanA/vanB delivers on-demand results in less than an hour, reducing the window for potential transmissions from days to minutes. Rapid intervention can prevent VRE transmissions - improving patient care and reducing costs for healthcare facilities.

VRE: A growing concern

  • The European Antimicrobial Resistance Surveillance System indicates that infection rates with vancomycin-resistant enterococci (VRE) are increasing, particularly in countries with high MRSA prevalence.
  • The proportion of invasive vancomycin resistant E. faecium isolates reached 37% in Greece, 33% in Ireland, 29% in Portugal, 21% in the UK and 15% in Germany
  • The percentage of invasive vancomycin resistant E. faecalis was found to be more than 6% in Greece and more than 2% in Portugal, Ireland and the UK

The Solution

CDC, SHEA and WHO have put forward the following guidelines on how to reduce VRE infections:

  • Comprehensive surveillance for targeted Multi-Drug Resistant Organisms; especially for those at high risk
  • Judicious use of antibiotics
  • Application of infection control precautions during patient care
  • Education and training of healthcare personnel
  • Environmental cleanliness
  • Decolonization therapy when appropriate

The Impact

Important healthcare benefits of rapid screening:

  • Allows for an immediate identification of VRE carriers from non-carriers
  • Rapid implementation of barrier precaution
  • Early identification improves patient bed management

Ordering Info

Xpert® vanA/vanB

Number of Tests: 10

Catalog #: GXVANA/B-CE-10

Xpert® vanA/vanB

Number of Swabs: 50

Catalog #: 900-0370

Educational Materials

Back to Top